Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-24 | Amended | $8,064,826 | $6,964,826 | Equity Only | 06b | SEC link |
| 2023-02-15 | New | $1,100,000 | $1,100,000 | Equity Only | 06b | SEC link |
| 2021-12-16 | Amended | $1,522,000 | $1,172,000 | Debt Only | 06b | SEC link |
| 2020-04-17 | New | $350,000 | $350,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mark De Souza | Director |
| Cristina Larkin | Director |
| Jayakumar Rajadas | Director |
| Curtis Scribner | Director |
| Matthew Tindall | Director, Executive |